Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4358-4365

  Katznelson, Laurence ^a   Finkelstein, Joel S ^a   Schoenfeld, David A ^a   Rosenthal, Daniel I ^a   Anderson, Ellen J ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPOGONADISM; LIBIDO; MALE; PRIORITY JOURNAL; STEROID THERAPY; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; TRABECULAR BONE;

ADULT; AGED; BODY COMPOSITION; BONE DENSITY; BONE DEVELOPMENT; CHOLESTEROL, HDL; GROWTH HORMONE; HUMANS; HYPOGONADISM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARATHYROID HORMONE; TESTOSTERONE;

EID: 0029838823     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4358     Document Type: Article

References (42)

1. Rudman D, Mattson DE, Nagraj HS, Feller AG, Jackson DL, Rudman IW. 1988 Plasma testosterone in nursing home men. J Clin Epidemiol. 41:231-236.
2. Tenover JS. 1994 Androgen administration to aging men [Review]. Endocrinol Metab Clin North Am. 23:877-892.
3. Abbasi A, Mattson DE, Cuisinier M, et al. 1994 Hyposomatomedinemia and hypogonadism in hemiplegic men who live in nursing homes. Arch Phys Med Rehab. 75:594-599.
4. Seidell JC, Bjomtorp P, Sjostrom L, Kvist H, Sannerstedt R. 1990 Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metab Clin Exp. 39:897-901.
5. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. 1990 Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Publ Health. 80:871-873.
6. Cooper C, Campion G, Melton LD. 1992 Hip fractures in the elderly: a world-wide projection. Osteopor Int. 2:285-289.
7. Melton LJ. 1988 Riggs BL, Melton LJ, eds. Osteoporosis: etiology, diagnosis, and management. New York: Raven Press; 133-154.
8. Seeman E, Melton LD, O'Fallon WM, Riggs BL. 1983 Risk factors for spinal osteoporosis in men. Am J Med. 75:977-983.
9. Seeman E. 1995 The dilemma of osteoporosis in men. Am J Med. 98:78S-85S.
10. Stanley HL, Schmitt BP, Poses RM, Deiss WP. 1991 Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men [see comments]? J Am Ger Soc. 39:766-771.
11. Jackson JA, Riggs MW, Spiekerman AM. 1992 Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci. 304:4-8.
12. Finkelstein JS, Klibanski A, Neer RM, et al. 1989 Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 69:776-783.
13. Diamond T, Stiel D, Posen S. 1991 Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 6:39-43.
14. Arisaka O, Arisaka M, Nakayama Y, Fujiwara S, Yabuta K. 1995 Effect of testosterone on bone density and bone metabolism in adolescent male hypegonadism. Metab Clin Exp. 44:419-423.
15. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM. 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med. 331:1618-1623.
16. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley Jr W. 1987 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 106:354-361.
17. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. 1986 Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 104:777-782.
18. Finkelstein JS, Cleary RL, Butler JP, et al. 1994 A comparison of lateral versus anterior-posterior spine dual energy x-ray absorptiometry for the diagnosis of osteopenia. J Clin Endocrinol Metab. 78:724-730.
19. Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V. 1988 Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab. 67:124-130.
20. Rosenthal DI, Ganott MA, Wyshak G, Slovik DM, Doppelt SH, Neer RM. 1985 Quantitative computed tomography for spinal density measurement. Factors affecting precision. Invest Radiol. 20:306-310.
21. Cameron JR, Sorenson J. 1963 Measurement of bone mineral in vivo: an improved method. Science. 142:230-232.
22. Mayo-Smith W, Hayes CW, Biller BM, Klibanski A, Rosenthal H, Rosenthal DI. 1989 Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 170:515-518.
23. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. 1990 Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner. 8:87-96.
24. Richardson ML, Genant HK, Cann CE, et al. 1985 Assessment of metabolic bone diseases by quantitative computed tomography. Clin Orthopaed Rel Res. 195:224-238.
25. De Pergola G, Xu X, Yang S, Giorino R, Bjorntorp P. 1990 Upregulation of androgen receptor binding in male rat fat adipose precursor cells exposed to testosterone: study in a whole cell assay system. J Steroid Biochem Mol Biol. 37:553-558.
26. Xu X, De Pergola G, Bjorntorp P. 1990 The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology. 126:1229-1234.
27. Marin P, Oden B, Bjorntorp P. 1995 Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab. 80:239-243.
28. Urban RJ, Bodenburg YH, Gilkison C, et al. 1995 Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 269:E820-E826.
29. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. 1989 Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clinl Endocrinol Metab. 69:523-527.
30. 6-GnRH). J Clin Endocrinol Metab. 76:288-290.
31. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 75:1092-1098.
32. Bellido T, Jilka RL, Boyce BF, et al. 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest. 95:2886-2895.
33. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ. 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 124:1576-1578.
34. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ. 1991 Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int. 49:183-187.
35. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [see comments]. N Engl J Med. 331:1056-1061.
36. Schweikert HU, Rulf W, Niederle N, Schafer HE, Keck E, Kruck F. 1980 Testosterone metabolism in human bone. Acta Endocrinol (Copenh). 95:258-264.
37. Morley JE, Perry HD, Kaiser FE, et al. 1993 Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 41:149-152.
38. Francis RM, Peacock M, Aaron JE, et al. 1986 Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone. 7:261-268.
39. Hagenfeldt Y, Linde K, Sjoberg HE, Zumkeller W, Arver S. 1992 Testosterone increases serum 1,25-dihydroxyvitamin D and insulin-like growth factor-I in hypogonadal men. Int J Androl. 15:93-102.
40. Weissberger AJ, Ho KK. 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab. 76:1407-1412.
41. Oppenheim DS, Greenspan SL, Zervas NT, Schoenfeld DA, Klibanski A. 1989 Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. Ann Intern Med. 111:288-292.
42. Bagatell CJ, Knopp RH, Vale WW, Rivier JE, Bremner WJ. 1992 Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels [see comments]. Ann Intern Med. 116:967-973.